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The modeling of glutamate/GABA-glutamine cycling in the brain tissue involving astrocytes,
glutamatergic and GABAergic neurons leads to a complex compartmentalized metabolic
network that comprises neurotransmitter synthesis, shuttling, and degradation. Without
advanced computational tools, it is difficult to quantitatively track possible scenarios and
identify viable ones. In this article, we follow a sampling-based computational paradigm
to analyze the biochemical network in a multi-compartment system modeling astrocytes,
glutamatergic, and GABAergic neurons, and address some questions about the details of
transmitter cycling, with particular emphasis on the ammonia shuttling between astrocytes
and neurons, and the synthesis of transmitter GABA. More specifically, we consider the
joint action of the alanine-lactate shuttle, the branched chain amino acid shuttle, and the
glutamine-glutamate cycle, as well as the role of glutamate dehydrogenase (GDH) activity.
When imposing a minimal amount of bound constraints on reaction and transport fluxes, a
preferred stoichiometric steady state equilibrium requires an unrealistically high reductive
GDH activity in neurons, indicating the need for additional bound constants which were
included in subsequent computer simulations.The statistical flux balance analysis also sug-
gests a stoichiometrically viable role for leucine transport as an alternative to glutamine for
replenishing the glutamate pool in neurons.
Keywords: GABAergic, GABA cycling, flux balance analysis, Markov chain Monte Carlo, nitrogen metabolism
1. INTRODUCTION
In the glutamate/GABA-glutamine cycle of neurotransmission,
where the ammonium fixation is essential in the synthesis of
glutamine in astrocyte, a natural question still waiting for a defin-
itive answer is how the ammonium pool in astrocyte is replen-
ished (1, 2). The tight coupling between reactions and transports
involved in neurotransmitter synthesis and cycling within the
complex metabolic network, and the distribution of the functions
into different compartments makes it hard, if not impossible, to
manually follow the fate of the metabolites and to identify in quan-
titative terms stoichiometrically feasible steady states. The com-
putational challenge, hampering standard optimization schemes,
is rooted in the indeterminacy of the governing system of mass
balance equations, which allows a continuum of possible solu-
tions, and is made worse by the need of introducing bounds on
some of the flux rates, for example imposing positivity to exclude
solutions that are either thermodynamically impossible or would
require physiologically unfeasible conditions. The statistical sam-
pling approach provides one viable approach for the in silico study
of complex metabolic networks (3–7).
In order to shed some light on the nitrogen metabolism
and shuttling of amino groups between astrocytes and neu-
rons during inhibition, we propose a complex, eight compart-
ment metabolic model which comprises astrocytes, glutamatergic,
and GABAergic neurons, each equipped with separate cytosol
and mitochondria. We perform a statistical flux balance analy-
sis of the metabolic pathway during inhibitory activity and ver-
ify whether the amino group shuttling mechanisms proposed in
the literature are supported by the results of our computational
simulations.
The focus of the present in silico study is on the synthesis and
cycling of the inhibitory neurotransmitter GABA, with the spe-
cific aim of elucidating the source and fate of amino groups and
ammonia during the GABA cycle. Among the different reaction
capable of generating ammonia in the brain, phosphate-activated
glutaminase, predominantly expressed in neurons, is considered
the major source of cerebral endogenous ammonia (1). Various
mechanisms have been proposed for transporting ammonia from
neurons,where it is released, to astrocytes,where it is needed for the
glutamine synthesis, including a diffusive process of ammonia, the
alanine-lactate shuttle, and the branched chain amino acid shut-
tle (1, 2). Although the basic mechanisms of the shuttles are well
understood, by considering the joint action of them rather than
each one of them separately and isolated from others, a different
picture of their role may emerge.
2. THE PATHWAY MODEL
The template for the metabolic models that we test in this article is
an eight compartment model, developed on the basis of the model
in Calvetti and Somersalo (8), comprising separate cytosol and
mitochondrial compartments for astrocytes, glutamatergic and
GABAergic neurons, as well as blood and extracellular space (ECS)
compartments, the latter one accounting also for the synaptic cleft,
which in some models constitutes a separate compartment (9).
Each cell compartment is equipped with detailed cytosolic gly-
colytic pathway, including the reversible lactate dehydrogenase
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(LDH), and mitochondrial tricarboxylic acid (TCA) cycle and
oxidative phosphorylation (OxPhos).
The complete malate-aspartate shuttle (MAS) included in each
cell consists of the oxoglutarate carrier (OGC) exchanging malate
(Mal) and α-ketoglutarate (AKG), and the aspartate-glutamate
carrier (AGC1). To complete the shuttle, cytosol and mitochon-
dria are equipped with aspartate aminotransferases (cAAT and
mAAT, respectively), as well as with reversible malate dehydroge-
nases, converting oxaloacetate (OAA) to malate in cytosol (cMDH)
or vice versa in mitochondria (mMDH).
Both glutamatergic and GABAergic neurons are equipped with
mitochondrial malic enzyme (mME) (10), while in astrocyte malic
enzyme is located in cytosol (cME) (11). Mitochondrial pyruvate
carboxylase (PC) is included in astrocytes only (12).
Cytosolic glutamate (Glu) is packed in vesicles by presynap-
tic glutamatergic neurons and released to the synaptic cleft, from
where it is quickly taken up by astrocytes. The astrocyte-specific
enzyme glutamine synthetase (GS) located in the cytosol of astro-
cyte (13) catalyzes the amidation of glutamate to glutamine (14).
The basic glutamate-glutamine cycle is completed by phosphate-
activated glutaminase (PAG) which is believed to be located in
the mitochondrial intermembrane (15). Since PAG replenishes the
cytosolic glutamate pool, we include it in our model as a cytosolic
enzyme in both glutamatergic and GABAergic neuron.
The inhibitory neurotransmitter γ -aminobutyric acid (GABA)
is released by the GABAergic neurons into the synaptic cleft, and
further taken up by the astrocytes. The GABA synthesis is cat-
alyzed by the enzyme glutamic acid decarboxylase (GAD). This
is a cytosolic enzyme with different isoforms (16) that are not
distinguished in our analysis, and assumed to be present both in
astrocytes and neurons.
Besides the neurotransmission, both glutamate and GABA play
a role in the cell metabolism, thus complicating the tracking of
amino groups in the network to determine their fate. GABA can
enter the mitochondria through a mechanism not completely
understood (17). In our model, the GABA permeation is assumed
to take place through a GABA carrier, although a GABA/glutamate
antiporter mechanism has been suggested (18), and recently iden-
tified and described in cell membranes of prokaryotes (19).
After entering mitochondria, GABA can be transaminated by the
enzyme GABA transaminase (GABA-T) to succinate semialdehyde
(SSA), and subsequently converted by succinate semialdehyde
dehydrogenase (SSADH) to succinate (Suc) (20). These reactions
constitute the GABA shunt, providing an alternative route from
α-ketoglutarate to succinate bypassing some TCA reactions. By
GABA-T, α-ketoglutarate forms glutamate, which can be further
transaminated by mAAT, transported into cytosol, or alternatively
oxidized to α-ketoglutarate by the enzyme glutamate dehydroge-
nase (GDH), which facilitates a bidirectional reaction; however, at
the physiological ammonium concentrations and redox levels, the
oxidative direction of the reaction is strongly favored (1, 21).
In addition to the AAT, glutamate may participate in other
transaminase processes. We include in our model the bidi-
rectional cytosolic alanine transaminase (ALT), in which ala-
nine (Ala) is transaminated to pyruvate, while α-ketoglutarate
forms glutamate. This reaction, together with LDH, constitutes
the lactate-alanine cycle (22, 23) proposed as a carrier of the
ammonium (NH+4 ) between astrocytes and neurons.
Another important shuttle of the amino group identified in
the brain tissue is the branched chain amino-transferase (BCAT),
which is a cytosolic enzyme (BCATc) in neurons and mitochon-
drial (BCATm) in astrocyte (24). For simplicity, we use leucine
(Leu) as a common representative of the three branched chain
amino acids (BCAA) (leucine, isoleucine, and valine), and α-
ketoisocaproate (KIC) as the representative of the correspond-
ing branched chain α-ketoacids (BCKA). In mitochondria, α-
ketoisocaproate can be oxidized to acetyl-coenzyme-A (ACoA),
although preferably reaminated back to BCAA (25). The BCAAs
have been suggested to constitute an important alternative for
shuttling ammonia between astrocyte and neuron.
As pointed out above, our model allows the passage of GABA
through the mitochondrial membrane by a mechanism that has
not been identified in mammalian brain. Cytosolic glutamate,
on the other hand, has access to mitochondria through the
ACG1 exchanger. Similarly, we include in our model a glutamate-
hydroxyl carrier (GC) that allows the passage of glutamate through
the mitochondrial membrane without tight coupling with aspar-
tate (20). In addition, we allow the passage of malate through
the mitochondrial membrane by the dicarboxyl carrier (26). Like-
wise, we assume a transport mechanism for branched chain amino
acids and α-ketoisocaproate across the astrocytic mitochondrial
membrane.
In our model, the three cell types can uptake glucose (Glc) from
the ECS compartment, and exchange oxygen (O2), carbon dioxide
(CO2), ammonium, and lactate (Lac). Following Cooper (1), we
do not distinguish between ammonium and ammonia, although a
detailed modeling of the diffusion through the membranes would
deserve more attention. We also assume a mechanism for pass-
ing branched chain amino acids, α-ketoisocaproate and alanine
between the cells and ECS. In contrast to our earlier models, aspar-
tate is not included as an exchangeable substance because it is not
believed to be an appropriate shuttle between the cells due to its
excitatory nature (27, 28).
The substances exchanged between blood and ECS compart-
ments include glucose, lactate, oxygen, carbon dioxide, ammo-
nium, alanine, leucine, and glutamine. Although there is evidence
of the presence of glutamate transporters at the blood-brain-
barrier (BBB) (29), we assume here that the clearance by astro-
cytes is fast enough for the glutamate transport to be considered
insignificant.
The energetic cost of neural activity is hard to estimate purely
on a stoichiometric basis: The energetic needs of the cycling of
the neurotransmitters constitute only a part of the total cost that
includes the membrane potential homeostasis, signal propagation,
and vesicle formation. In Attwell and Laughlin (30), a careful sto-
ichiometric analysis of the energetic need of glutamate cycling
between neurons and astrocytes leads to an estimate of approx-
imately three ATP per each glutamate molecule. However, the
authors point out that the total energetic need is higher. The
energetic needs of astrocytes is even less well known. Part of
the difficulty of incorporating a stoichiometrically justified figure
for the energetic cost stems from the lumped nature of the model
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which needs to integrate non-local ion translocation processes in
a well-mixed compartment representation.
A semi-empirical approach has been suggested in the previ-
ous works of the authors (31, 32), and we will be adopt a similar
approach in this paper. In Sibson et al. (33) it was empirically
shown that in rat brain, the cerebral metabolic rate (CMR) of glu-
cose in neurons is in almost 1:1 proportion to the glutamate flux,
an observation that has been corroborated by several groups. A
refined analysis was given by Hyder et al. (34), estimating that the
total neurotransmitter cycle flux of glutamate is 68% of the total
neuronal oxidative CMR of glucose, while the total neurotrans-
mitter cycle flux of GABA is 21% of the total neuronal oxidative
CMR of glucose. Estimating that each completely oxidized mol-
ecule of glucose produces 30–38 ATP molecules, depending on
details included, we may conclude that the total cost for maintain-
ing each unit of glutamate flux corresponds to 21–26 units of ATP
converted to ADP+Pi (no GABAergic activity), and 6–8 units
of ATP for maintaining one unit of GABA flux (no glutamater-
gic activity). As demonstrated in Calvetti and Somersalo (8), in
spite of its coarseness, in simulations these flux estimates yield an
energetic cost that correspond well to the data reported in Sibson
et al. (33).
For simplicity, we include in our model a virtual vesicular
compartment in the cytosol of glutamatergic and GABAergic neu-
rons, and attach the total energetic cost in the flux of packing the
neurotransmitters in the vesicular form, see Table 1 for details.
The energetic cost of astrocytic neurotransmitter recycling is
only partly known: the cost of glutamine synthetase and Na+/H+
extrusion after ion co-transport with glutamate is assessed at about
2ATP/glutamate in Attwell and Laughlin (30). In the present paper
we use this stoichiometry for GABA recycling, understanding that
it may underestimate the total energetic cost for astrocyte func-
tions. In fact, experimental data suggest that astrocytes use from
15% to more than 25% of brain energy (35–37) for various func-
tions, including K+ clean-up and calcium signaling, neither of
which is explicitly accounted for in the model. To counterbalance
the underestimate, our model enables the cells to use energy for
unspecified activities by including an ATP hydrolysis in each cell.
As pointed out in Calvetti and Somersalo (8), the activity level
of this flux, in particular in astrocytes, can be significantly ele-
vated. Details will be given later when the computed examples are
described.
A complete list of the reactions included in the model is given in
Table 1. The configuration described by our model refers to well-
mixed compartments in which the input variables are specified
target levels of the cerebral metabolic rates of glucose and lactate,
and the brain activity is simulated by specifying, in terms of target
flux values, the efflux of the pertinent neurotransmitter, which in
the present investigation is GABA. Table 2 lists the transport fluxes
of selected species between some of the compartments.
3. COMPUTATIONAL APPROACH
Under steady state hypotheses, the metabolic model is charac-
terized by reaction fluxes and transport rates that must be in
stoichiometric equilibrium. Each reaction Ri within a specific
compartment is assigned a reaction flux ϕi. Similarly, if a sub-
strate is exchanged between two adjacent compartments through
a transport Ti, the latter is assigned a transport rate ji, expressed
in the same units as the reaction fluxes. The reaction fluxes and
transport rates are then collected in an array, the flux-transport
vector u,
u =
[
ϕ
j
]
, with ϕ =
ϕ1...
ϕn
 , j =
 j1...
jk
 , (1)
where n and k are the total number of reactions and transports in
the system.
Given a transport Ti or a reaction Ri, we define the stoi-
chiometric vector si by specifying the number of units of each
biochemical species in each compartment which are either pro-
duced or depleted if the transport or reaction runs alone for one
time unit. Thus, the length of each stoichiometric vector equals
the total number of species in the compartment model. Observe
that a metabolite appearing in several compartments is counted
as a different species in each compartment. After arranging the
stoichiometric vectors as the columns of the stoichiometric matrix,
A = [s1 s2 · · · sn+k] , (2)
the steady state equilibrium condition for the flux-transport vector
can be expressed in the form
Au = r . (3)
Above, the vector r describes the transport rates of substances
to and from outside the compartment model: its entries are all
zeros for compartments that are not communicating with the out-
side world through convection or diffusion, while for the species
exchanged through BBB and the blood flow, they represent the
CMRs of the tissue sample that the model is describing. For further
details, see Table 3.
The reaction fluxes and transport rates are subject to bound
constraints: a flux ϕi of a reaction Ri that is thermodynamically
possible only in one direction must respect the positivity condition
ϕi> 0. Following the Bayesian paradigm, some of the positivity
bounds may be purely a priori bounds, meaning that a positiv-
ity constraint may be implemented if there is a good reason to
believe that a net flux of a bidirectional reaction or transport has
a preferred direction, such as oxygen entering rather than exiting
the tissue (38). Further, we may assume that all the reaction fluxes
and transport rates must be bounded by some, possibly large,
upper bound V max. The system of linear constraints is expressed
in matrix form as
Cu ≥ c , (4)
where c is a vector with as many entries as we have the inequality
constraints, the matrix C contains the coefficients of the lin-
ear expressions in the inequalities, and the matrix inequality is
assumed to hold component-wise.
Methods for finding a feasible flux-transport vector satisfying
equation (3) with bounds equation (4) are discussed in the classi-
cal flux balance analysis (FBA) literature, see, e.g., Kauffman et al.
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Table 1 | List of reactions included in the metabolic network model.
Reaction cA mA cGlt mGlt cGA mGA
Glycolysis GLC+ATP→G6P+ADP × × ×
G6P+ATP→2GA3P+ADP × × ×
GA3P+Pi+NAD+→BPG+NADH × × ×
BPG+2ADP→Pyr+2ATP × × ×
LDH Pyr+NADH
Lac+NAD+ × × ×
ALT Pyr+Glu
Ala+AKG × × ×
ATP-H ATP→ADP+Pi × × ×
GAD Glu→GABA+CO2 × × ×
PAG Gln→Glu+NH+4 × ×
MDH OAA+NADH
Mal+NAD+ × × ×
AAT Asp+AKG
OAA+Glu × × × × × ×
ME Pyr+CO2+NADH
Mal+NAD+ × × ×
GS Glu+NH+4 +ATP→Gln+ADP+Pi ×
GDH Glu+NAD+
AKG+NH+4 +NADH × × ×
PDH Pyr+CoA+NAD+→ACoA+NADH+CO2 × × ×
PC Pyr+CO2+ATP
OAA+ADP+Pi ×
TCA cycle ACoA+OAA→CIT+CoA × × ×
CIT+NAD+→AKG+CO2+NADH × × ×
AKG+CoA+NAD+→SCoA+CO2+NADH × × ×
SCoA+ADP+Pi→Suc+CoA+ATP × × ×
Suc+NAD+→Fum+NADH × × ×
Fum→Mal × × ×
Mal+NAD+→OAA+NADH × × ×
GABA-T GABA+AKG→SSA+Glu × × ×
SSADH SSA+NAD+→Suc+NADH × × ×
BCAT Leu+AKG
KIC+Glu × × ×
BCKDH KIC+CoA→ACoA+CO2 × × ×
OxPhos O2+6ADP+6Pi+2NADH→6ATP+2NAD+ × × ×
Virtual reactions with energetic cost
Glu+25ATP→Gluvesicular+25ADP+25Pi ×
GABA+8ATP→GABAvesicular+8ADP+8Pi ×
The symbol “→” is used for irreversible reactions, while “
” is used for reversible ones. The relevant abbreviated enzyme acronyms referring to the corresponding
reactions are indicated in the first column.The columns refer to compartments that are the locus of the enzyme: cA/mA, cytosol/mitochondria of astrocyte; cGlt/mGlt,
cytosol/mitochondria of glutamatergic neuron; cGA/mGA, cytosol/mitochondria of GABAergic neuron. The virtual reactions, transporting glutamate and GABA to a
virtual vesicular compartment for neurotransmission are included to attach an undifferentiated energetic cost for the total neurotransmitter cycling, see text for
justification.
(39). A well-known problem in FBA is the lack of a unique solu-
tion, i.e., the stoichiometry and bounds alone are not sufficient to
identify a unique steady state. It is this non-uniqueness which gives
the system the flexibility to adjust to changing physiological condi-
tions. Rather than forcing the uniqueness of the solution by adding
extra conditions, a task which may require constructing artificial
objectives for the system, we seek to explore computationally the
full set of feasible steady state configurations. The methodology to
achieve this, which is based on a probabilistic description of the
problem, has been developed in a series of papers by the authors,
see, e.g., Heino et al. (7); Calvetti and Somersalo (8); Calvetti et
al. (9), and references therein. We give a concise overview of the
approach below.
In this probabilistic setting, feasible flux-transport vectors are
assumed to be distributed in the space of all vectors so as to
approximately satisfy both the equilibrium condition equation (3)
while strictly respecting the bound constraint inequality (4). This
is achieved by defining a truncated Gaussian probability density
pi (u) ∝ H (Cu − c) exp
(
−1
2
(Au − r)T6−1 (Au − r)
)
. (5)
Here, “∝” stands for “proportional to,” H is the multidimensional
Heaviside function that vanishes except when all the components
of the vector Cu− c are positive, in which case it assumes the
value one, and 6 is a covariance matrix, which we assume to be
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Table 2 |The transports implemented in the model.
Blood ECS Cytosol Mitochondria
Glc • → • → • •
Lac • ↔ • ↔ • •
Pyr • • • → •
O2 • → • → • → •
CO2 • ← • ← • ← •
NH+4 • → • ↔ • ↔ •
Leu • → • ↔ • ↔ •
KIC • • ↔ • ↔ •
Ala • ↔ • ↔ • •
ATP • • • ↔ •
ADP • • • ↔ •
Pi • • • ↔ •
Glu • • ↔ • ↔ •
GABA • • ↔ • ↔ •
Gln • ← • ↔ • ↔ •
Malate-aspartate shuttle (MAS)
OGC Mal (cyto)+AKG (mito)→Mal (mito)+AKG (cyto)
AGC1 Glu (cyto)+Asp (mito)→Glu (mito)+Asp (cyto)
In the columns, “→” and “←” mean that the transport has been implemented
as unidirectional in the direction indicated by the arrow, while “↔” means that
a priori no preferred direction is specified. Observe that in the numerical simula-
tions, we may implement bound constraints that limit the direction of some of
the reactions and transports, as indicated in the text.
Table 3 | Input values defining the non-vanishing components of the
right hand side r in equation (3).
rj=Q/F (Caj − Cvj ) Q=0.55 F =1
Caj − Cvj Caj Cvj
Glc 0.54±0.05 – –
Lac −0.18±0.02 – –
O2 (free and bound) – 9.15±0.5 Estimated
CO2 (free and bound) – 23±1 Estimated
0±0.2 – –
Leu 0±0.1 – –
Gln 0±0.1 – –
The system is scaled so that it corresponds to 1 g tissue. The units of the blood
flow Q are milliliter per minute, the mixing ratio F is unit free, and the concen-
trations are given in micromoles per milliliter. The flux values are expressed in
micromoles per minute. In the table, “estimated” means that the quantity is
included in the list of unknowns and estimated together with the flux values.
Observe that the formula for rj above for oxygen and carbon dioxide refers to
concentrations of free gases, and a conversion from bound to free needs to be
performed [see, e.g., Ref. (51)].
diagonal. The diagonal entries of6 express how tightly each one of
the steady state equations is enforced. We refer to the square roots
of these entries as standard deviations of the model equations.
A rather stringent condition is required in our calculations: the
standard deviation is set to σ = 0.005µmol/min for every model
equation, except for equations that define the influx/efflux from
blood to ECS. The latter standard deviations are given in Table 3.
To investigate feasible steady state configurations with some
of the fluxes close to a desired target value, the distribution can
be modified accordingly in a simple way: the belief that a given
flux or transport u`, such as the efflux of a given neurotransmit-
ter, should be close to a target value u
target
` , can be implemented
by augmenting the probability density equation (5) with an extra
factor,
pi (u)→ pi (u)× exp
(
− 1
2w2
(
u` − utarget`
)2)
, (6)
where w > 0 is the standard deviation controlling how stringently
the target value is pursued. We specify the values of these parame-
ters later on. To explore the resulting probability density, and thus
the distribution of all feasible flux-transport configurations, we
use Markov chain Monte Carlo (MCMC) techniques to generate
a representative sample of those vectors,
S = {u1, u2, . . . , uN }, (7)
such that for N large, the vectors uj are, at least asymptotically, dis-
tributed according to the probability density pi(u). For details, see
Heino et al. (7). Based on this sample, we obtain a summary sta-
tistics of the distribution, e.g., by computing the sample mean and
variance. In the sequel, we shall use almost exclusively the sample
mean as a representative flux-transport configuration for a given
stoichiometric model with bounds and target controls defined in
equations (4) and (6).
The values for the input parameters used in the computations
are given in Table 3.
4. QUANTITATIVE ANALYSIS OF AMMONIUM SHUTTLING
It is commonly accepted that the glutamate and GABA neuro-
transmitter cycling between neurons and astrocyte is completed by
the glutamine transport, following the glutamate/glutamine cycle
for excitatory transmission between the glutamatergic neuron and
astrocyte, or the GABA/glutamine cycle for the inhibitory trans-
mission between GABAergic neuron and astrocyte. Both cycles
require the ammonium fixation by GS in astrocytic cytosol, and
metabolizing glutamine into glutamate in neuron by PAG. In both
transmitter cycles, a stoichiometric shortage of one NH+4 in the
astrocytic cytosol, and excess of one NH+4 in the neuronal cytosol
ensues, see Figure 1.
As pointed out in Rothman et al. (2), the stoichiometric
imbalance requires one of the following alternatives to take place:
1. the excess NH+4 in the neuronal cytosol diffuses via ECS to the
astrocyte, probably in the form of NH3, or
2. the excess NH+4 in the neuronal cytosol diffuses in the mito-
chondria and is fixed to α-ketoglutarate by GDH to form
glutamate.
The former alternative readily resumes the stoichiometric equi-
librium of ammonia, while the latter requires a further shuttling
mechanism to restore the balance. In the literature, different
mechanisms have been proposed.
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Glu
Gln
NH
4
ATP
ADP
GS
Gln
Glu
NH
4
PAG
Gln
Glu
PAG
NH
4
GABA
GAD
GABA
FIGURE 1 |The glutamate-glutamine cycle and GABA-glutamine
cycles. The excess ammonium freed by PAG in the neurons needs to be
transported back to astrocyte, where a shortage is created by the GS
activity. In the pure glutamate/GABA-glutamine cycle paradigm, the
ammonium diffusion or surrogate shuttle mechanisms need to go at the
flux rate of the glutamine efflux from astrocyte. The quantitative analysis
indicates that the full picture may be more complex.
In the alanine-lactate shuttle (22), the mitochondrial glutamate
in neuron enters cytosol either by the AGC1 exchanger or the GC
carrier, and consequently is transaminated to α-ketoglutarate by
ALT, while concurrently forming alanine from pyruvate. In this
scenario, alanine is then shuttled to astrocyte, where it is transam-
inated to pyruvate by ALT, concomitantly forming glutamate from
α-ketoglutarate. To attain the carbon balance, pyruvate is shuttled
from astrocyte to neuron in the form of lactate, produced by LDH,
which converts lactate to pyruvate in a reverse reaction in neuron.
We refer to Figure 2 for an illustration.
An alternative shuttle mechanism uses the branched chain
amino acids, leucine in particular in our model, as carriers of
the amino group. In this scenario, glutamate is transaminated
to α-ketoglutarate by BCATc in the cytosol of the neuron, while
α-ketoisocaproate is converted into leucine. The branched chain
amino acids and corresponding keto acids are then exchanged
between the neuron and the astrocyte, and the reverse reaction,
facilitated by BCATm, produces glutamate and α-ketoisocaproate
in the mitochondria of the astrocyte. This shuttle mechanism is
illustrated schematically in Figure 3.
Several factors complicate the analysis of the interplay between
the various shuttling mechanism, including the following:
1. The different mechanisms are probably completing each other,
none of them alone compensating the ammonium imbalance;
2. Glutamate has a complex role, being not only a neurotransmit-
ter but also a metabolite;
3. The two proposed shuttling mechanisms require that GDH
in neuron runs in the reductive direction with a significant
flux, which has been experimentally and theoretically been
questioned as a possible option;
AKG
Glu
NH
4
Ala
Pyr
GDH
ALT
Lac Lac
Pyr
NH
4
Glu
AKGAla
ALT GDH
ASTROCYTE NEURON
LDH LDH
FIGURE 2 |The lactate-alanine cycle between astrocyte and neuron.
Observe that in order to complete the cycle, lactate needs to move from
astrocyte to neuron. The shuttle is in redox equilibrium, since in both cells
the oxidative (red arrows) and reductive (blue arrows) reactions
compensate each other. However, in order for this shuttle to be efficient at
transferring ammonium, it requires reductive activity of the GDH in the
neuronal mitochondria, a scenario that has been questioned in the literature
both for theoretical reasons and in the light of experimental evidence (1).
AKG
Glu
NH
4
Leu
KIC
GDH
BCATm
KIC
NH
4
Glu
AKGLeu
BCATc GDH
ASTROCYTE NEURON
FIGURE 3 |The branched chain amino acid cycle. In order to effectively
move the NH+4 from neuron to astrocyte, the latter has to be fixed to
α-ketoglutarate by mitochondrial GDH, thus requiring this reaction to go in
the reductive direction, hence running into the same criticism as the
lactate-alanine shuttle (see Figure 2).
4. both NH+4 and leucine are assumed to be replenished from
the blood, while glutamine may leak out, making the shuttling
mechanisms stoichiometrically leaky.
These are some of the considerations which make a flexible
computational tool for following the fluxes particularly attractive.
5. NUMERICAL SIMULATIONS
In Calvetti and Somersalo (8), three different simulated activa-
tion levels were considered: Excitation state, characterized by high
glutamate efflux from glutamatergic neuron, awake state, defined
by moderate glutamate efflux, and inhibition state, in which the
GABA efflux from GABAergic neuron is set at a specified level.
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These states are not intended to model the whole brain, which is
known to be predominantly glutamatergic (40, 41), but rather a
small portion of it that is assumed to correspond to the prescribed
activity. Without specifying the volume of the domain modeled,
we scale the fluxes to correspond a volume of one gram tissue. Our
in silico analysis focuses on inhibitory activity, which is achieved
by defining a target value for the GABA efflux from the GABAergic
neuron (nGABA). In equation (6), we choose
u` = jGABAnGABA→ECS, utarget` = 0.13 µmol/min.
This is the level of inhibitory activity state used in Calvetti and
Somersalo (8), based on the experimental analysis in Shulman et
al. (42) and Hyder et al. (34). Here, only the inhibitory activation
state is considered as a representative of complex interplay between
the astrocytes and the two neuron types.
The parameter w in equation (6) defining the standard
deviation of the GABA flux from the target value is set to
w = 0.005µmol/min. While it is understood here that the GABA
efflux should be a response to some excitatory activity, we do not
explicitly specify the level of excitatory activity in the model, but
rather let it be determined by the stoichiometry. By the way the
model is set up, the uptake of nutrients, oxygen, and glutamine of
the glutamatergic neuron settle to some levels that satisfy the equi-
librium conditions. In the various simulations with the current
model discussed later, the mean glutamate efflux from glutamater-
gic neurons to ECS is 0.08–0.09µmol/min. The energy demand of
the astrocytes, measured in terms of mean ATP turnover, in all our
simulations is approximately 45% of the total ATP turnover. This
indicates a high oxidative activity of astrocyte during inhibition,
which is in line with the earlier computational results (8) as well
as with experimental findings (37, 43).
Using the software package Metabolica, we generate a sample of
N = 200,000 sample vectors un, each of them representing a pos-
sible equilibrium or near-equilibrium flux configuration. In the
following analysis, we report for the most part the mean transport-
flux vector that is obtained by averaging over the sample, that is,
we define the mean u by
u = 1
N
N∑
n=1
un .
We run three different tests, differing from each other by the
imposed positivity constraints specified below, designed to put
the focus on ammonium traffic and GABA formation.
5.1. OXIDATIVE GDH AND AMMONIA DIFFUSION
In the first computational simulation, we constrain the directions
of some key important fluxes. To analyze the ammonium uptake
pattern, we first assume that GDH in all cell types goes in the
oxidative rather than reductive direction, that is,
GDH : Glu +NAD+ → AKG+NH+4 +NADH, ϕGDH ≥ 0.
(8)
These constraints constitute three rows in the system equation
(4), one corresponding to each cell type.
In addition, we prescribe the direction of the branched chain
amino acid transport from ECS to astrocyte (ast), by implementing
the positivity constraint
jLeuECS→ast ≥ 0, (9)
constituting an additional row in the system equation (4). We point
out that this constraint is an a priori bound, included to make the
model conform with the proposed shuttle mechanism as well as
with the observation that leucine is predominantly taken up by
astrocytes rather than neurons (44, 45). The effect of removing
the constraint is also investigated later on.
5.1.1. Ammonium traffic through ECS
As expected, the bound constraint equation (8) disables the
ammonium fixation in the neuron, and therefore makes both the
alanine-lactate shuttle and the BCAA shuttle ineffective as possible
pathways for trafficking NH+4 from neuron to astrocyte. Figure 4
summarizes quantitatively the ammonium trafficking between the
compartments under the constraint equation (8).
There are two explanations why the NH+4 flux from ECS into
the astrocyte is not equal to the glutamine efflux from astrocyte
to ECS. First, the tissue takes up leucine from the blood, which in
turn is taken up by astrocyte, thus providing a source of ammo-
nium. Second, some of the glutamine synthesized in astrocyte is
released in the blood and is thus removed from the system. We
observe that the NH+4 flux out of the neurons is slightly higher
than the glutamine flux into the neurons. The difference is due
to the oxidation of glutamate in neurons, GDH oxidizing glu-
tamate to α-ketoglutarate. The percentage of glutamine-derived
glutamate which is oxidized is about 14% in glutamatergic neu-
ron and 22% in GABAergic neuron. Also, there is a slight offset
between the ammonium uptake flux of the astrocyte and the glu-
tamine efflux. The difference, or missing ammonium in astrocyte,
is compensated by the uptake of leucine from the blood.
5.1.2. Glutamine as precursor of GABA
The simplified picture of the GABA/glutamine cycle is that gluta-
mine is taken up by GABAergic neuron, transformed to glutamate
by PAG and further to GABA by GAD. Our analysis indicates
that while this core chain is valid, the full picture is much more
complicated. The mean fluxes indicate that the GAD activity
(0.2µmol/min) is more than twice the PAG (0.09µmol/min)
activity, raising the question of the origin of the extra glutamate
in the cytosol of the GABAergic neuron. Mitochondrial gluta-
mate can be replenished via three transaminases (AAT, ALT, and
BCAA), and two transport mechanisms (AGC1 and glutamate-
hydroxyl carrier GC) from the cytosol. As indicated in Figure 5, in
a combined action, they exactly account for the excess glutamate.
Another noteworthy detail is that the GAD produces not only the
neurotransmitter GABA, but also a significant amount of GABA
that is oxidized in the mitochondria, corresponding to about 35%
of all GABA produced by GAD. The GABA entering mitochondria
feeds the GABA shunt, the rate of which is slightly less than 50% of
the total TCA cycle flux measured by the succinate dehydrogenase
flux. This result is in line with the experimental results in rat brain
reported in Hassel et al. (46).
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FIGURE 4 |The transport rates of glutamine and ammonium
between ECS and other compartments. The numbers indicated in the
figure are in units micromoles per minute per 1 g tissue. Observe that
the ammonium flux into the astrocyte is 0.02µmol/min smaller than the
glutamine efflux. The imbalance, however, is compensated by the influx
of leucine from blood to ECS, as indicated in the figure. The net influx of
NH+4 carried by leucine into astrocyte turns out to be exactly
0.02µmol/min.
5.2. BIDIRECTIONAL GDH AND THE ROLE OF AMINO GROUP SHUTTLES
The results reported in the previous section demonstrate quite
clearly that without neuronal GDH running in the reductive direc-
tion, both the lactate-alanine shuttle and the branched chain
amino acid shuttle play only a marginal role in the ammonium
group traffic. This observation underlines the difficulty of rec-
onciling the proposed shuttle mechanisms with experimental
observations that brain tissue is incapable of ammonium fixing
even under hyperammonemic conditions (21, 47, 48). To test
computationally the viability and mutual equilibrium values of
these shuttles, we repeat the sampling, removing the constraint
inequality (8) from all cell types, which is tantamount to allowing
bidirectional GDH activity. What we anticipate in this case is a
rather significant reductive GDH activity in both neuron types.
Figure 6 shows the smoothed histograms of the GDH activity in
each cell type, indicating also the sample mean. The histograms
indicate that a wide range of GDH activity levels are possible. How-
ever, in equilibrium conditions and with no bound constraints for
the GDH, the fluxes seek to balance the reductive activity in neu-
rons (ϕGDH< 0) by the oxidative activity in astrocyte (ϕGDH> 0).
Because this equilibrium is not possible when the direction of the
activity is restricted, the mismatch was balanced with ammonium
diffusion between the cells.
When GDH is assumed to be able to operate in both directions,
it is possible to reduce, or even reverse the NH+4 diffusion from
neuron to astrocyte by replacing it with the two shuttle mecha-
nisms discussed in Section 4. The schematics in Figure 7 illustrate
the mechanism in astrocyte that removes the ammonium from
alanine and leucine via a joint action of GDH and the transami-
nases ALT and BCATm. The mean flux values in the figure indicate
that the two shuttle mechanisms have almost the same level of
activity. Moreover, the rate of the NH+4 production by this process
is almost twice as large as the flux of GS depleting it: the residual
NH+4 is released to ECS, from where it is taken up by the neurons.
Therefore, the combined action of the two shuttle mechanisms, in
the mean flux configuration, not only replaces the need for ammo-
nium diffusion, but in fact, overwhelms it. This finding suggests
that the mean flux configuration with freely reversible GDH in the
neurons may not represent a physiologically meaningful steady
state.
One of the attractive features of the sampling-based approach
to metabolic networks is that from the full sample of steady state
configurations, it is possible to select subsamples of states that
satisfy physiologically more meaningful bounds. In the present
case, we select only those reaction-transport vectors uj for which
the net ammonium flux from ECS into the cytosol of astrocyte
is positive. Restricting the analysis to this subsample, we recom-
pute the mean fluxes. Figure 8 shows the smoothed histograms
of the subsampled GDH fluxes in each cell type. Interestingly, the
mean GDH activity in the GABAergic neurons vanishes, while in
the astrocyte and in the glutamatergic neurons GDH runs, in the
mean, at the same low rate but in opposite direction. The counter-
part of Figure 7 with mean fluxes calculated from the subsample
are shown in Figure 9. The numbers indicate that about one fifth
of the ammonium required by the GS originates from the GDH,
while the rest enters the astrocyte by diffusion from the ECS.
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FIGURE 5 |The fates of glutamine in the GABAergic neuron. All
glutamine is transformed into glutamate in the cytosol by PAG, after
which the pathway branches. The three transaminases with
respective flux rates (cBCAT, ALT, and AAT) are marked in red.
Observe that the rate of GAD is more than twice the rate of
glutamine uptake and PAG. Of all GABA produced, 35% enters the
mitochondria where it is transaminated by GABA-T and further
oxidized. The glutamine influx comprises about 70% of the
transmitter GABA efflux, although the complex pathway pattern
complicates the tracking of the precursors.
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FIGURE 6 |The smoothed histograms of the GDH fluxes in each of the three cell types, calculated from the sample of 200,000 realizations. The sample
mean in each cell is indicated by the vertical line. Observe that the sum of the mean activities in the neurons equal the negative of the astrocytic activity.
5.3. BRANCHED CHAIN AMINO ACID SHUTTLE: AN ALTERNATIVE FOR
GLUTAMINE CYCLE?
The BCAA shuttle, which has been suggested as a vehicle for
returning the ammonia freed by PAG in neuron into the astrocyte
for fixation by GS, requires the questionable reductive action of
GDH in neuron. When we remove the bound constraint inequality
(9) on the direction of the transport of leucine, the pathway analy-
sis tool Metabolica suggests an alternative function for BCAA that
cannot be excluded by stoichiometric considerations alone. A stoi-
chiometric equilibrium can be found in which BCAA is running in
the reverse direction, transaminating astrocytic α-ketoisocaproate
to leucine, which is transported to neuron, where the reverse reac-
tion (Leu+AKG→KIC+Glu) replenishes the glutamate pool.
In other words, leucine assumes the role of glutamine as a pre-
cursor of transmitter glutamate and GABA. This shuttle does
not completely replace the glutamine as a precursor of glutamate
in the mean equilibrium state, but acts as an additional source.
The analysis suggests also that, when leucine can be taken up
by neuron, the alanine-lactate shuttle runs in the direction sug-
gested in Waagepetersen et al. (22), as shown in Figure 10. The
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FIGURE 7 | Reactions in the astrocyte that liberate ammonium from
alanine and leucine transported into astrocyte from the neurons
when allowing a bidirectional GDH activity. The values refer to the
mean fluxes over a 200,000 sample. The oxidative GDH activity is higher
than the GS flux, leading to an excess of NH+4 which is transported to the
ECS and further taken up by neurons. This mean flux configuration may
not be physiologically meaningful because of the unexpected efflux of
NH+4 from astrocyte.
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FIGURE 8 |The smoothed histograms of the GDH fluxes in each of the three cell types, calculated from the subsample of the flux vectors in which the
NH+4 flux goes in the direction ECS→astrocyte. The sample mean in each cell is again indicated by the vertical line.
situation is similar for the astrocyte and GABAergic neuron pair,
in which the action of GAD from glutamate to GABA needs to be
incorporated.
6. CONCLUSION AND PERSPECTIVES
In this work, we investigate the neurotransmitter cycling in a
steady state multi-compartment model using the computational
tool Metabolica, with a particular emphasis on the traditional
glutamate/GABA-glutamine cycling scenario between astrocytes
and neurons. The basic brain metabolism multi-compartment
model is enriched with other cycling mechanisms, such as
branched chain amino acid shuttle and alanine-pyruvate shut-
tle. The focus in this work is on the stoichiometric implications of
selected bound constraints on some of the key reaction fluxes and
transport rates. This work is bridging the earlier computational
works on brain energy metabolism by the authors with recently
published works on neurotransmitter synthesis and cycling, [see
Ref. (2, 49)]. As pointed out in Sibson et al. (33) and several
other studies later on, the neurotransmitter cycling activity and the
energy metabolism are tightly coupled, and therefore any model
for one has implications for the other. However, the modeling par-
adigm adopted here which is based on modeling the reaction and
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FIGURE 9 |The corresponding fluxes as in Figure 7, calculated as a
mean over a subsample of those sample vectors for which the NH+4
flux is from ECS into the astrocyte. The ammonia influx and the GDH
flux add up to equal the GS flux. Observe that the GDH runs at a much
lower rate than the two transaminases, and the corresponding
lactate-alanine shuttle and the branched chain amino acid shuttle,
demonstrating that considering the isolated shuttle mechanisms may be
misleading.
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FIGURE 10 |The branched chain amino acid cycle can provide a
stoichiometrically viable alternative for the traditional
glutamate-glutamine cycle. Leucine is transported from astrocyte to
neuron, where it is transaminated to α-ketoisocaproate, forming glutamate
from α-ketoglutarate. Unlike the glutamate-glutamine cycle, this cycle
requires no return traffic of ammonia. A stoichiometric equilibrium can be
found in which the GDH runs in oxidative direction in all cells, and the
combined action of alanine-lactate shuttle and GDH replenishes the NH+4 pool
in astrocyte. A flux of NH+4 from neuron to astrocyte is still needed for
equilibrium.
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transport fluxes in terms of distributions indicate that within the
same energetic level, measured in terms of tissue glucose uptake,
it is possible to find a range of stoichiometrically viable scenarios
that differ in the details about the shuttling of the amino groups
between the various cell types. As demonstrated in the article,
the sample based approach makes it possible to narrow down the
distributions by means of subsampling, thus excluding realiza-
tions that represent steady state configurations that lead to model
predictions which are in conflict with observations.
The main findings of the article may be summarized in few
points: first, if the GDH is only allowed to run in the oxidative
direction in the neurons, as the experimental data suggest, a sig-
nificant diffusion of NH+4 from neuron to astrocyte is needed to
compensate the ammonium imbalance due to the GS-PAG activ-
ity. If, however, the reductive action of GDH is allowed with no
further restrictions, the model seeks an equilibrium in which the
GDH overcompensates, and the diffusion of NH+4 is reversed,
going from astrocytes to neurons. Since this scenario does not
seem plausible in the light of what is known experimentally, we
selected from the sample of possible equilibrium states those flux
vectors in which the ammonium traffic goes from ECS into the
astrocyte, leading to an equilibrium in which the GDH activity
is significantly reduced, and the equilibrium state is more in line
with experimental observations.
Finally, we point out that if the branched chain amino acid
shuttle is not restricted to run in the direction suggested in
the literature, with leucine entering astrocyte, a viable equilib-
rium can be found, in which leucine plays a role of glutamine,
enriching the glutamate pool in neuron without the need of
compensating NH+4 diffusion from neuron to astrocyte. In our
model, this glutamate/GABA-leucine cycle does not replace the
traditional glutamate/GABA-glutamine cycle, but completes it.
Although experimental evidence supports the uptake of leucine
predominantly by astrocytes rather than neurons, the stoichiomet-
ric viability of this shuttle may be of interest under some atypical
conditions.
The role that advanced statistical computational models may
have in the brain research is to point out scenarios and alternative
patterns in the complex metabolic network that may not be evi-
dent, and may be hard to find by simple flux balance analysis. In
this way, the analysis may turn out to be useful as a guideline for
designing new experiments. As pointed out in Rowley et al. (50),
the details of neurotransmitter and amino group cycling are par-
ticularly important since they provide potential targets for drug
discovery to control, e.g., epileptic seizures, hepatic encephalopa-
thy, various mental disorders, or progression of neurodegenerative
diseases.
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